#inmazeb — Public Fediverse posts

A somewhat dark factoid of the immense corporate CYA behind such drugs - here for #Inmazeb / #Ebanga - but alike in so many other drugs and vaccines for many hemorrhagic fevers - is that the adverse reactions to the drugs are vastly similar to the onset symptoms of the diseases. "fever, rash, muscle pains" are all common symptoms of most viral hemorrhagic fevers.

You KNOW they are tap-dancing when they start listing the disease's symptoms among possible side effects

It's worth adding that the "therapeutics" for #Ebola are immensely expensive, and seriously unavailable to the poorest communities which are often the most affected.

Last year, Regeneron provided 500 doses of #Inmazeb. It treats around 45 patients, at most. See link.

https://investor.regeneron.com/news-releases/news-release-details/regeneron-donates-ebola-treatment-use-countries-most-risk

It's worth adding that the "therapeutics" for #Ebola are immensely expensive, and seriously unavailable to the poorest communities which are often the most affected.

Last year, Regeneron provided 500 doses of #Inmazeb. It treats around 45 patients, at most. See link.

https://investor.regeneron.com/news-releases/news-release-details/regeneron-donates-ebola-treatment-use-countries-most-risk

People now clickbaiting the specific strain of #Ebola, #Bundibugyo, shrieking about the WHO statement that there are "no vaccines or therapeutics".

Perspective. The ONLY vaccines for Ebola were "approved" under emergency use (2020), then "compassionate use" clause, last year (#PALM trial). They are either a monoclonal antibody (#Ebanga) or a cocktail of three monoclonal antibodies (#Inmazeb).

People now clickbaiting the specific strain of #Ebola, #Bundibugyo, shrieking about the WHO statement that there are "no vaccines or therapeutics".

Perspective. The ONLY vaccines for Ebola were "approved" under emergency use (2020), then "compassionate use" clause, last year (#PALM trial). They are either a monoclonal antibody (#Ebanga) or a cocktail of three monoclonal antibodies (#Inmazeb).